You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

MAXIBOLIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Maxibolin patents expire, and when can generic versions of Maxibolin launch?

Maxibolin is a drug marketed by Organon Usa Inc and is included in two NDAs.

The generic ingredient in MAXIBOLIN is ethylestrenol. Additional details are available on the ethylestrenol profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MAXIBOLIN?
  • What are the global sales for MAXIBOLIN?
  • What is Average Wholesale Price for MAXIBOLIN?
Summary for MAXIBOLIN
US Patents:0
Applicants:1
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 12
Patent Applications: 936
DailyMed Link:MAXIBOLIN at DailyMed
Drug patent expirations by year for MAXIBOLIN

US Patents and Regulatory Information for MAXIBOLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc MAXIBOLIN ethylestrenol ELIXIR;ORAL 014006-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Organon Usa Inc MAXIBOLIN ethylestrenol TABLET;ORAL 014005-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

MAXIBOLIN Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Anabolic Steroids: A Case Study on MAXIBOLIN

Introduction

Anabolic steroids, including compounds like MAXIBOLIN, are synthetic derivatives of testosterone that have been widely misused for performance enhancement and bodybuilding. Understanding the market dynamics and financial trajectory of these substances is crucial for addressing their misuse and the associated health risks.

What is MAXIBOLIN?

MAXIBOLIN, often referred to by its active ingredient Methandienone, is a well-known anabolic steroid. It is a 17α-methylated derivative of testosterone, designed to enhance muscle growth and strength.

Historical Context and Development

MAXIBOLIN was first introduced in the 1950s and quickly gained popularity among athletes and bodybuilders due to its potent anabolic effects. However, its use has been marred by significant health risks and legal issues[4].

Market Demand and User Profile

The demand for MAXIBOLIN and other anabolic steroids is driven primarily by athletes, bodybuilders, and individuals seeking to enhance their physical appearance. A national study found that more than 6% of male high school seniors in the U.S. have used or are using anabolic steroids, highlighting the widespread misuse among young athletes[4].

Legal and Regulatory Environment

The use and distribution of MAXIBOLIN are heavily regulated. In the U.S., the Anti-Drug Abuse Act of 1988 classified anabolic steroids as controlled substances, making their non-medical use illegal. Similar laws exist in other countries, such as the UK, where anabolic steroids are classified as Class C drugs[4][5].

Black Market and Smuggling

Despite legal restrictions, MAXIBOLIN and other anabolic steroids are widely available on the black market. Investigations, such as the Canada Border Services Agency's Project Trajectory, have uncovered extensive smuggling rings involving large quantities of these substances. The estimated annual sales of black market steroids are around $300 to $400 million[2][4].

Financial Trajectory

The financial trajectory of MAXIBOLIN and similar anabolic steroids is marked by significant illicit revenue. Here are some key financial aspects:

  • Sales and Revenue: The black market sales of anabolic steroids, including MAXIBOLIN, generate hundreds of millions of dollars annually. For instance, a single investigation in Canada uncovered an estimated $715,000 worth of anabolic steroids[2].
  • Production and Distribution Costs: The costs associated with producing and distributing these substances are relatively low compared to their resale value. This makes the black market for anabolic steroids highly lucrative[4].

Health Risks and Economic Impact

The misuse of MAXIBOLIN and other anabolic steroids comes with severe health risks, including liver damage, heart problems, and psychological issues. These health consequences impose a significant economic burden on healthcare systems.

"The problem with steroids is that they work, so people use them and see a drastic improvement. However, they also come with a plethora of side effects that are not talked about, from short-term acute issues to long-term effects such as depression, scarring acne, or erectile dysfunction," said a doctor in a UK parliamentary debate[5].

Law Enforcement and Seizures

Law enforcement agencies around the world are actively working to combat the illegal trade of anabolic steroids. For example, in 2021, the UK Border Force seized 1.225 million doses of anabolic steroids, although convictions for possession or supply remain relatively low[5].

Market Dynamics: Supply and Demand

The supply of MAXIBOLIN and other anabolic steroids is driven by clandestine manufacturing, smuggling, and diversion from legitimate medical channels. Demand is fueled by the desire for physical enhancement and performance improvement, particularly among athletes and bodybuilders.

Impact on Legitimate Pharmaceutical Market

The illicit trade in anabolic steroids undermines the legitimate pharmaceutical market. Legitimate manufacturers face competition from cheaper, black market alternatives, which can lead to financial losses and reputational damage.

Future Outlook

Given the persistent demand and the lucrative nature of the black market, it is likely that MAXIBOLIN and other anabolic steroids will continue to be misused. However, increased awareness of the health risks and stricter enforcement of laws could potentially reduce their prevalence.

Key Takeaways

  • MAXIBOLIN is a widely misused anabolic steroid with significant health risks.
  • The black market for anabolic steroids generates hundreds of millions of dollars annually.
  • Health risks associated with anabolic steroid use impose a substantial economic burden.
  • Law enforcement efforts are ongoing to combat the illegal trade.
  • The legitimate pharmaceutical market is affected by the illicit trade in these substances.

FAQs

Q: What are the primary health risks associated with MAXIBOLIN use?

A: The primary health risks include liver damage, heart problems, psychological issues such as depression, scarring acne, and erectile dysfunction[5].

Q: How is MAXIBOLIN typically distributed on the black market?

A: MAXIBOLIN is often distributed through clandestine manufacturing, smuggling, and diversion from legitimate medical channels. It can also be purchased through online platforms like Instagram[2][5].

Q: What are the legal consequences of using or distributing MAXIBOLIN?

A: Using or distributing MAXIBOLIN without a prescription is illegal and can result in significant fines and imprisonment. In the UK, it is classified as a Class C drug, and distribution is strictly prohibited[4][5].

Q: How prevalent is the use of anabolic steroids among athletes?

A: The use of anabolic steroids is significant among athletes, with over 6% of male high school seniors in the U.S. reported to have used these substances. The prevalence extends to college and professional athletes as well[4].

Q: What efforts are being made to combat the misuse of anabolic steroids?

A: Law enforcement agencies are conducting investigations and seizures to curb the illegal trade. Additionally, there is an increasing emphasis on education and awareness about the health risks associated with anabolic steroid use[2][5].

Sources

  1. Medicinal Use of Testosterone and Related Steroids Revisited - MDPI
  2. CBSA investigation into steroid smuggling ring leads to guilty pleas and sentences - Canada Border Services Agency
  3. Recent market dynamics affecting the GHIP - Delaware Health and Social Services
  4. DRUG MISUSE Anabolic Steroids and Human Growth Hormone - GAO
  5. Performance-enhancing Drugs and Body Image - Hansard

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.